Comprehensive bloodwork + physician evaluation, only $99 to get started. Test your levels →
If you’re considering hormone therapy, whether for menopause symptoms, low testosterone, or age-related hormonal decline, you’ve likely encountered two terms: BHRT (bioidentical hormone replacement therapy) and traditional or conventional HRT. The distinction between them is more than marketing. It involves real differences in molecular structure, metabolism, customization, and safety data.
This guide breaks down the clinical differences to help you make an informed decision alongside your provider.
Traditional hormone replacement therapy refers to the hormone products that dominated clinical practice from the 1960s through the early 2000s. The two most prescribed were:
These products were widely prescribed and formed the basis of the Women’s Health Initiative (WHI) study, the landmark trial that raised safety concerns about hormone therapy in 2002. For decades, these two products essentially were hormone therapy in mainstream medicine.
Bioidentical hormone replacement therapy uses hormones that are structurally identical to the hormones your body produces naturally. The most commonly used bioidentical hormones include:
These hormones are available as FDA-approved commercial products and as custom-compounded formulations prepared by specialty pharmacies. The defining feature is molecular identity with human hormones, not the source material or how they’re manufactured.
For a comprehensive overview of bioidentical therapy, see our Complete Guide to Bioidentical Hormone Therapy.
This is the most fundamental difference and the one from which most others follow.
Traditional HRT: Uses hormones with altered molecular structures. Medroxyprogesterone acetate has an acetate group attached to the progesterone molecule, changing how it interacts with receptors and how the body metabolizes it. Conjugated equine estrogens contain multiple estrogen variants, several of which are foreign to human biology.
BHRT: Uses hormones whose molecular structure is identical to endogenous human hormones. Estradiol is estradiol. Progesterone is progesterone. The body processes these through the same pathways it would use for its own hormones.
When the molecular structure differs, so does the metabolism.
Micronized progesterone is metabolized to allopregnanolone, a neurosteroid that promotes calm, reduces anxiety, and supports deep sleep. This is the same metabolite your body produces from its own progesterone. Medroxyprogesterone acetate does not produce allopregnanolone, which may explain why many women on synthetic progestins report mood disturbances, anxiety, and poor sleep.
Similarly, transdermal estradiol is metabolized through the same pathways as endogenous estradiol, while oral conjugated equine estrogens undergo first-pass liver metabolism and produce different metabolite profiles, including increased production of clotting factors.
The safety conversation around hormone therapy was shaped primarily by the WHI study, which used CEE + MPA. The key findings included increased risk of breast cancer, cardiovascular events, and blood clots in the CEE + MPA arm.
However, subsequent research has painted a more nuanced picture:
These findings suggest that the specific hormones used, the delivery method, and the timing of initiation all matter significantly, and that the WHI results should not be generalized to all hormone therapy.
For a detailed safety analysis, see Is Bioidentical Hormone Therapy Safe? What the Research Says.
Traditional HRT: Available in standardized, fixed-dose commercial products. Patients receive pre-set doses, with limited ability to fine-tune.
BHRT: Can be customized in multiple dimensions:
This level of individualization is a cornerstone of the BHRT approach. Your provider at BHRT Boost designs a protocol built around your unique lab panel, not a population average.
Traditional HRT is typically managed by OB-GYN or primary care providers using standardized treatment algorithms. The goal is often symptom management at the lowest effective dose.
BHRT is more commonly managed by providers trained in age management medicine, functional medicine, or anti-aging medicine, providers like Dr. Bruce Stratt who specialize in hormone optimization. The goal goes beyond symptom relief to comprehensive hormonal optimization, using detailed lab data to target levels associated with vitality, not just the absence of disease.
| Factor | Traditional HRT | BHRT |
|---|---|---|
| Molecular structure | Altered (synthetic progestins, equine estrogens) | Identical to human hormones |
| Primary estrogen | Conjugated equine estrogens (CEE) | Estradiol (E2) |
| Progestogen | Medroxyprogesterone acetate (MPA) | Micronized progesterone |
| Metabolites | Non-human; MPA does not produce allopregnanolone | Human-identical; progesterone → allopregnanolone |
| Delivery options | Primarily oral pills and patches | Creams, pellets, injections, patches, troches, oral |
| Customization | Fixed-dose commercial products | Individualized compounding + commercial options |
| Lab monitoring | Often minimal | Comprehensive and ongoing |
| Clinical goal | Symptom relief at lowest dose | Full hormonal optimization |
| WHI applicability | Directly studied | Not directly studied (different molecules) |
The choice between traditional HRT and BHRT should be made with a provider who understands the clinical differences and can guide you based on your specific labs, symptoms, and health history.
Factors that may favor BHRT include:
If you’re currently on traditional HRT and considering a switch, your provider can help you transition safely. The first step is always a comprehensive lab panel to establish a clear baseline.
BHRT and traditional HRT are not the same therapy with different names. They differ at the molecular level, which affects how the body processes them, their side effect profiles, and the clinical outcomes they produce. While traditional HRT has decades of clinical data, some reassuring, some concerning, the specific products studied in the WHI are not representative of bioidentical hormones.
BHRT offers molecular identity with human hormones, greater customization, and a safety profile supported by a growing body of evidence. When administered under proper clinical oversight with comprehensive lab monitoring, it represents a more individualized, data-driven approach to hormone optimization.
For a deeper look at bioidentical hormones, explore our Complete Guide to BHRT or read about bioidentical hormones vs synthetic for an additional clinical perspective.
Ready to explore whether BHRT is right for you? Book a consultation →
BHRT Boost Clinical Team
Our clinical team combines decades of experience in hormone optimization, functional medicine, and patient-centered care. Every article is reviewed for medical accuracy and practical relevance.
An evidence-based comparison of bioidentical and synthetic hormones, molecular differences, how the body metabolizes each, safety evidence, and why the distinction matters for your treatment.
A comprehensive guide to hormone therapy during menopause, what happens to your hormones, treatment options, the role of bioidentical hormones, safety evidence, and how to find the right protocol.
An evidence-based look at the safety of bioidentical hormone therapy, what the clinical trials show, how BHRT differs from conventional HRT in safety data, and why proper medical oversight matters.
Comprehensive bloodwork + physician evaluation by Dr. Stratt, MD.
